Bristol-Myers Squibb Co (BMY) Stock Price & News

Symbols Symbols	Trend	Change	Price	Change	% Change	Prev Close	Open	High	Low	Volume	Mkt Cap
SIXB Materials SIXB Materials	SIXB -0.94%	—	1,068.83 -0.94%	1,068.83	-10.14	-0.94%	1,078.97	1,079.20	1,079.20	1,066.24	—	—
SIXC Communications SIXC Communications	SIXC +2.13%	—	600.47 +2.13%	600.47	+12.55	+2.13%	587.92	587.92	601.69	587.92	—	—
SIXE Energy SIXE Energy	SIXE -0.91%	—	1,351.60 -0.91%	1,351.60	-12.39	-0.91%	1,363.99	1,376.24	1,382.15	1,344.42	—	—
SIXI Industrials SIXI Industrials	SIXI -1.44%	—	1,710.25 -1.44%	1,710.25	-25.05	-1.44%	1,735.30	1,727.73	1,727.73	1,695.29	—	—
SIXM Financials SIXM Financials	SIXM -0.35%	—	701.68 -0.35%	701.68	-2.46	-0.35%	704.14	705.01	708.07	698.34	—	—
SIXR Staples SIXR Staples	SIXR +1.19%	—	850.57 +1.19%	850.57	+10.02	+1.19%	840.55	846.63	855.11	846.63	—	—
SIXRE Real estate SIXRE Real estate	SIXRE -0.66%	—	211.43 -0.66%	211.43	-1.40	-0.66%	212.83	212.83	213.59	210.64	—	—
SIXT Technology SIXT Technology	SIXT -1.86%	—	3,708.10 -1.86%	3,708.10	-70.28	-1.86%	3,778.38	3,690.47	3,734.85	3,665.22	—	—
SIXU Utilities SIXU Utilities	SIXU -1.34%	—	841.80 -1.34%	841.80	-11.45	-1.34%	853.25	852.23	854.23	840.62	—	—
SIXV Health care SIXV Health care	SIXV +1.35%	—	1,691.74 +1.35%	1,691.74	+22.61	+1.35%	1,669.13	1,685.15	1,702.42	1,685.13	—	—
SIXY Discretionary SIXY Discretionary	SIXY -0.10%	—	2,276.85 -0.10%	2,276.85	-2.37	-0.10%	2,279.22	2,267.50	2,285.94	2,262.80	—	—

BMY:NYSE

Bristol-Myers Squibb Co

$64.10

+0.72%

(+0.46) Today

Closed: Sep 14, 4:00:06 PM GMT-4 · USD

$63.98

-0.19% (-0.12)

After hours · 4:00 AM

YTD

MAX

	Symbol	Price	Change	% Change	Prev Close

Generating top insights for BMY...

Open

$64.59

High

$65.29

Low

$63.91

Mkt. cap

130.94B

Avg. vol.

9.80M

Volume

302.00

Dividend

3.93%

Quarterly dividend

$0.63

Ex-dividend date

Jul 2, 2026

P/E ratio

14.12

52-wk high

$68.64

52-wk low

$42.52

EPS

$4.54

Beta

0.23

Shares outstanding

2.04B

No. of employees

32K

Open

$64.59

High

$65.29

Low

$63.91

Mkt. cap

130.94B

Avg. vol.

9.80M

Volume

302.00

Dividend

3.93%

Quarterly dividend

$0.63

Ex-dividend date

Jul 2, 2026

P/E ratio

14.12

52-wk high

$68.64

52-wk low

$42.52

EPS

$4.54

Beta

0.23

Shares outstanding

2.04B

No. of employees

32K

Related stocks

News stories

From web sources and news partners

ad-hoc-news.de

2 hours ago

Bristol Myers Squibb stock heads into the open after a 0.7% NYSE gain

Investing.com

19 hours ago

BioMarin appoints Bristol Myers Squibb executive to board

Kalkine Media

20 hours ago

Why Is Bristol-Myers Squibb (NYSE:BMY) Under NYSE Spotlight?

MarketBeat

1 day ago

Bristol Myers Squibb Company $BMY Shares Acquired by Corient Private Wealth LP

News Corp

1 day ago

Big Pharma Is Pouring Billions Into China’s Biotechs

Simply Wall Street

1 day ago

Bristol Myers Squibb (BMY) Reports Positive Phase 2 Data, Is The Stock Fully Valued?

Currently.com

1 day ago

Should You Buy Bristol Myers Squibb Stock Right Now for the Yield Alone?

Profile

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia

About Bristol-Myers Squibb Co

CEOChris Boerner

Employees32.5K

Founded1887

HeadquartersNew York, New York, United States

SectorPharmaceutical industry

Websitebms.com

Analyst	Recommendation	Action	Price target	Projected	Date
Trung Huynh RBC Capital	Hold	Maintained	$64.00	-0.2%	09/14/2026
Rajesh Kumar HSBC	Hold	Maintained	$65.00	+1.4%	09/10/2026
Louise Chen Scotiabank	Hold	Maintained	$60.00	-6.4%	09/09/2026
Evan Seigerman BMO Capital	Hold	Maintained	$60.00	-6.4%	09/09/2026
Courtney Breen Bernstein	Hold	Maintained	-	-	08/20/2026
Michael Yee UBS	Buy	Maintained	$80.00	+24.8%	08/20/2026
Geoff Meacham Citi	Hold	Maintained	$70.00	+9.2%	08/14/2026
Matt Phipps William Blair	Hold	Maintained	-	-	08/14/2026
Terence Flynn Morgan Stanley	Sell	Maintained	$40.00	-37.6%	08/14/2026
Emily Field Barclays	Buy	Reiterated	$75.00	+17%	08/11/2026
Jasper Hellweg Argus Research	Buy	Upgraded	$75.00	+17%	08/04/2026
Chris Schott J.P. Morgan	Buy	Maintained	$73.00	+13.9%	08/04/2026
Unknown Analyst Berenberg Bank	Hold	Maintained	$65.00	+1.4%	08/03/2026
Jason Gerberry Bank of America Securities	Buy	Reiterated	$71.00	+10.8%	08/03/2026
Carter Gould Cantor Fitzgerald	Hold	Maintained	$59.00	-8%	07/30/2026
Srikripa Devarakonda Truist Financial	Buy	Reiterated	$70.00	+9.2%	07/31/2026
Seamus Fernandez Guggenheim	Buy	Reiterated	$75.00	+17%	07/31/2026
Mohit Bansal Wells Fargo	Hold	Reiterated	$65.00	+1.4%	07/31/2026
David Amsellem Piper Sandler	Buy	Reiterated	$75.00	+17%	07/28/2026
Asad Haider Goldman Sachs	Hold	Maintained	$61.00	-4.8%	07/20/2026
Unknown Analyst Jefferies	Buy	Maintained	$73.00	+13.9%	06/01/2026
Unknown Analyst TD Cowen	Hold	Maintained	$57.00	-11.1%	05/18/2026
Unknown Analyst Erste Group	Hold	Maintained	-	-	04/01/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	12.22B	12.50B	11.49B	12.97B
Cost of goods sold	3.31B	3.51B	3.41B	3.71B
Cost of revenue	3.31B	3.51B	3.41B	3.71B
Research and development expenses	2.43B	2.56B	2.24B	2.54B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.79B	2.09B	1.61B	1.82B
Operating expense	5.05B	5.47B	4.28B	4.80B
Total operating expenses	8.36B	8.98B	7.69B	8.51B
Operating income	3.86B	3.52B	3.80B	4.46B
Other non operating income	529.00M	544.00M	125.00M	106.00M
EBT including unusual items	3.11B	1.47B	3.24B	4.09B
EBT excluding unusual items	4.07B	3.86B	3.65B	4.35B
Income tax expense	919.00M	384.00M	561.00M	770.00M
Effective tax rate	29.51%	26.12%	17.32%	18.84%
Other operating expenses	-	-	-	-
Net income	2.20B	1.09B	2.68B	3.32B
Net profit margin	18.01%	8.69%	23.30%	25.57%
Earnings per share	1.63	1.26	1.58	2.04
Interest and investment income	161.00M	148.00M	104.00M	101.00M
Interest expense	-482.00M	-432.00M	-406.00M	-403.00M
Net interest expenses	-321.00M	-284.00M	-302.00M	-302.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	4.91B	4.54B	4.41B	5.08B
Gain or loss from assets sale	-9.00M	-	-34.00M	-142.00M

Finance

Lists

Research